Blood Microbiota and Circulating Microbial Metabolites in Diabetes and Cardiovascular Disease

Publication date: Available online 11 February 2020Source: Trends in Endocrinology & MetabolismAuthor(s): Ganesan Velmurugan, Vasudevan Dinakaran, Jeyaprakash Rajendhran, Krishnan SwaminathanDiabetes and cardiovascular disease (CVD) have evolved as the leading cause of mortality and morbidity worldwide. In addition to traditional risk factors, recent studies have established that the human microbiota, particularly gut bacteria, plays a role in the development of diabetes and CVD. Although the presence of microbes in blood has been known for centuries, mounting evidence in this metagenomic era provides new insights into the role of the blood microbiota in the pathogenesis of non-infectious diseases such as diabetes and CVD. We highlight the origin and physiology of the blood microbiota and circulating microbial metabolites in relation to the etiology and progression of diabetes and CVD. We also discuss translational perspectives targeting the blood microbiota in the diagnosis and treatment of diabetes and CVD.
Source: Trends in Endocrinology and Metabolism - Category: Endocrinology Source Type: research